These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24481905)

  • 21. Effect of dexamethasone on albendazole cysticidal activity in experimental cysticercosis by Taenia crassiceps in BALB/c mice: In vitro and in vivo evaluation.
    Palomares-Alonso F; Toledo A; Palencia Hernández G; Jung-Cook H; Fleury A
    Exp Parasitol; 2020 Jan; 208():107801. PubMed ID: 31730781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic effects of anthelminthic drugs in the larval stage of the cestode Taenia crassiceps, cysticercosis experimental model - A review.
    Vinaud MC; Ambrosio J
    Acta Trop; 2020 Jun; 206():105448. PubMed ID: 32194066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
    Romo ML; Carpio A; Kelvin EA
    J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
    Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of neurocysticercosis: a review].
    Nogales-Gaete J; Arriagada C; Salinas R
    Rev Med Chil; 2006 Jun; 134(6):789-96. PubMed ID: 17130956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanodelivery of nitazoxanide: impact on the metabolism of
    Vinaud MC; Real D; Fraga CM; Lima NF; Souza Lino Junior R; Leonardi D; J Salomon C
    Ther Deliv; 2020 May; 11(5):329-339. PubMed ID: 32486970
    [No Abstract]   [Full Text] [Related]  

  • 28. Inflammation Caused by Praziquantel Treatment Depends on the Location of the Taenia solium Cysticercus in Porcine Neurocysticercosis.
    Cangalaya C; Zimic M; Marzal M; González AE; Guerra-Giraldez C; Mahanty S; Nash TE; García HH;
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004207. PubMed ID: 26658257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticysticercal treatment and seizures in neurocysticercosis.
    Singh G; Sander JW
    Lancet Neurol; 2004 Apr; 3(4):207-8. PubMed ID: 15039032
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental neurocysticercosis: absence of IL-4 induces lower encephalitis.
    Silva HM; Vinaud MC; Lino RS
    Arq Neuropsiquiatr; 2017 Feb; 75(2):96-102. PubMed ID: 28226078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal and intracranial experimental cysticercosis present different metabolic preferences after treatment with isolated or combined albendazole and nitazoxanide.
    de Andrade Picanço G; Ferreira de Lima N; Cristina Gomes T; de Sousa Mendes Moreira Alves D; Luísa da Costa T; Vinaud MC
    Acta Trop; 2022 Feb; 226():106264. PubMed ID: 34919953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A benzimidazole derivative (RCB20) in vitro induces an activation of energetic pathways on Taenia crassiceps (ORF strain) cysticerci.
    Fraga CM; da Costa TL; de Castro AM; Reynoso-Ducoing O; Ambrosio J; Hernández-Campos A; Castillo R; Vinaud MC
    Exp Parasitol; 2017 Jan; 172():12-17. PubMed ID: 27884580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocysticercosis.
    Del Brutto OH
    Handb Clin Neurol; 2014; 121():1445-59. PubMed ID: 24365429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
    Jung-Cook H
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro effects of albendazole sulfoxide and praziquantel against Taenia solium and Taenia crassiceps cysts.
    Palomares F; Palencia G; Pérez R; González-Esquivel D; Castro N; Cook HJ
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2302-4. PubMed ID: 15155240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studies.
    Palomares F; Palencia G; Ambrosio JR; Ortiz A; Jung-Cook H
    J Antimicrob Chemother; 2006 Mar; 57(3):482-8. PubMed ID: 16410266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
    Arroyo G; Bustos JA; Lescano AG; Gonzales I; Saavedra H; Rodriguez S; Pretell EJ; Bonato PS; Lanchote VL; Takayanagui OM; Horton J; Gonzalez AE; Gilman RH; Garcia HH;
    Clin Infect Dis; 2019 Nov; 69(11):1996-2002. PubMed ID: 30715265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taenia crassiceps: fatty acids oxidation and alternative energy source in in vitro cysticerci exposed to anthelminthic drugs.
    Vinaud MC; Ferreira CS; Lino Junior Rde S; Bezerra JC
    Exp Parasitol; 2009 Jul; 122(3):208-11. PubMed ID: 19348802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative screening for anticestode drugs based on changes in baseline enzyme secretion by Taenia crassiceps.
    Mahanty S; Madrid EM; Nash TE
    Antimicrob Agents Chemother; 2013 Feb; 57(2):990-5. PubMed ID: 23229489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis.
    Castillo G; Fustamante L; Delgado-Kamiche AD; Camen-Orozco RP; Clark T; Bernal E; Morales-Alvarez J; Ferrufino M; Mamani-Palomino J; Bustos JA; Garcia HH; Gavidia CM; Gilman RH; Verastegui M;
    Brain Pathol; 2024 Sep; 34(5):e13237. PubMed ID: 38212958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.